Complete News, Your Way.
Get Started
SubscribeLogin
Israel-Hamas Conflict
World Cup
Boxing
Elon Musk
WWE
Social Media
Donald Trump
Baseball
Natural Disasters
Soccer
Eid
Wrestling
Nintendo
Published • loading... • Updated

Zydus enters global biologics CDMO market with $75m Agenus facility acquisitions

Summary by BioProcess International
The deal includes exclusive manufacturing rights for Agenus's cancer immunotherapies.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
BioProcess InternationalBioProcess International

Zydus enters global biologics CDMO market with $75m Agenus facility acquisitions

The deal includes exclusive manufacturing rights for Agenus's cancer immunotherapies.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

BioProcess International broke the news in on Thursday, June 5, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Cancer

Cancer

News
For You
SearchBlindspotLocal